Pfizer Inc (NYSE:PFE)

40.51
Delayed Data
As of Jan 17
 -0.10 / -0.25%
Today’s Change
33.97
Today|||52-Week Range
44.56
+3.39%
Year-to-Date
2 Biotechs Battling Immune Diseases
Jan 19 / MotleyFool.com - Paid Partner Content
Is Pfizer's Stock a Buy?
Jan 14 / MotleyFool.com - Paid Partner Content
Why Pfizer Stock Fell 10.2% in 2019
Jan 16 / MotleyFool.com - Paid Partner Content
Biogen Buys Azheimer's and Parkinson's Drug From Pfizer
Jan 13 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Here's Why SpringWorks Therapeutics Climbed 69% in December
Jan 12 / MotleyFool.com - Paid Partner Content
New Research Shows Probiotics Can Help Prevent Parkinson's
Jan 14 / MotleyFool.com - Paid Partner Content
Here's Why Mylan Fell 26.6% in 2019
Jan 10 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
Why Pfizer Is My Drug Stock of Choice
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close40.61
Today’s open40.57
Day’s range40.42 - 40.81
Volume21,901,267
Average volume (3 months)18,766,466
Market cap$224.2B
Data as of 6:30pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)-46.78%
Earnings growth (this year)-1.03%
Earnings growth (next 5 years)+6.70%
Revenue growth (last year)+2.10%
P/E ratio14.2
Price/Sales4.86
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.83+0.87%
MRKMerck-0.21-0.23%
BMYBristol-Myers Squibb-0.06-0.09%
AZNAstraZeneca+0.82+1.62%
Data as of 6:30pm ET, 01/17/2020

Financials

Next reporting dateJanuary 28, 2020
EPS forecast (this quarter)$0.57
Annual revenue (last year)$53.6B
Annual profit (last year)$11.2B
Net profit margin20.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts